Heart Disease Clinical Trials in Houston

Showing 241-260 of 298 trials

Physician Uncertainty Reduction for Hypertension

NCT00201084

The purpose of this study is to test the theory that a major factor in poor blood pressure (BP) control is that physicians fail to intensify antihypertensive therapy for their patients.

Cardiovascular DiseasesHeart DiseasesHypertension

Baylor College of Medicine670 participantsStarted Sep 2004

Houston, Texas, United States

COMPLETEDPhase 4< 1 mile

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

NCT00153101

The Ongoing Telmisartan Alone and in combination wiht Ramipril Global Endpoint trial (ONTARGET): The primary objectives are to determine if (a) telmisartan 80mg daily and ramipril 10mg daily combination therapy is more effective in reducing the composite endpoint of Cardiovascular Death (CV) death, Myocardial infarction (MI), stroke or hospitalization for Congestive Heart Failure (CHF) compared with ramipril 10mg alone; and (b) telmisartan 80mg daily is at least as effective as (i.e. not less effective than) ramipril 10mg daily, on this endpoint. Telmisartan Randomised Assessment Study in Angiotension converting Enzyme inhibitor intolerant subjects with Cardiovascular Disease. (TRANSCEND): The primary objective of the study is to determine if treatment with telmisartan 80mg daily is superior to placebo reducing the composite endpoint of Cardiovascular Death (CV), Myocardial Infarction ( MI)I, stroke or hospitalization for Congestive Heart Failure (CHF) in patients who are intolerant to Angiotension Converting Enzyme inhibitors.

Cardiovascular Diseases

Boehringer Ingelheim31,546 participantsStarted Nov 2001

Athens, Alabama, United States • Birmingham, Alabama, United States • Phoenix, Arizona, United States +729 more locations

Physician Uncertainty Reduction for Hypertension

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Heart Disease Trials in Other Cities

TAXUS PERSEUS Workhorse

Radial Artery Versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery

Safety and Efficacy Study of YM087 (Conivaptan) in Patients With Acute Decompensated Heart Failure

Effects of Highly Active Anti-Retroviral Therapy on Cardiovascular Health in Infants of HIV-Infected Mothers

OMNI Study--Assessing Therapies in Medtronic Pacemaker, Defibrillator, and Cardiac Resynchronization Therapy Devices.

Rapid Assessment of Bedside BNP In Treatment of Heart Failure (RABBIT)

M. D. Anderson Symptom Inventory - Heart Failure (MDASI-HF) Symptom Management Program

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

A Thyroid Hormone Analog to Fight Heart Failure: Phase II Trial (DITPA)

Study to Evaluate the Safety and Efficacy of JVS-100 Administered to Adults With Ischemic Heart Failure.

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People

Study Evaluating How Patients With Acute Coronary Syndrome Are Managed During 2 Years After Discharge

Study of the Effectiveness and Safety of Niaspan ® in the Treatment of Lipid Abnormalities in Latin America

Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique

Other Conditions in Houston